Prescription Drug Coverage and Medicare Spending among U.S. Elderly

被引:3
|
作者
Shang, Baoping [1 ]
Goldman, Dana [2 ]
机构
[1] Urban Inst, Ctr Hlth Policy, Washington, DC 20037 USA
[2] Univ So Calif, Sch Policy Planning & Dev, Los Angeles, CA 90089 USA
关键词
prescription drugs; health insurance benefits; adverse selection; health care spending; HEALTH-CARE SERVICES; ADVERSE SELECTION; INSURANCE-COVERAGE; PHARMACY BENEFITS; MEDIGAP INSURANCE; COST-CONTAINMENT; IMPACT; COPAYMENT; OUTCOMES; REFORM;
D O I
10.1057/gpp.2010.21
中图分类号
F8 [财政、金融];
学科分类号
0202 ;
摘要
The introduction of Medicare Part D has generated interest in the cost of providing drug coverage to the elderly. Of paramount importance-often unaccounted for in budget estimates-are the salutary effects that increased prescription drug use might have on other Medicare spending. This paper uses longitudinal data from the Medicare Current Beneficiary Survey to estimate how prescription drug benefits affect Medicare spending. We compare spending and service use for Medigap enrollees with and without drug coverage. Owing to concerns about selection, we use variation in supply-side regulations of the individual insurance market-including guaranteed issue and community rating-as instruments for prescription drug coverage. We employ a discrete factor model to control for individual-level heterogeneity that might induce bias in the effects of drug coverage. We find Medigap prescription drug coverage significantly increases drug spending and reduces Medicare Part A spending. Medigap prescription drug coverage reduces Medicare Part B spending, but the estimates are not statistically significant. Furthermore, the substitution effect decreases as income rises, and thus provides support for the low-income assistance program of Medicare Part D. The Geneva Papers (2010) 35, 539-567. doi:10.1057/gpp.2010.21
引用
收藏
页码:539 / 567
页数:29
相关论文
共 50 条
  • [11] Prescription drug spending among medicare beneficiaries with chronic conditions: Trends and issues
    Boccuti, C
    Moon, M
    Dowling, K
    [J]. GERONTOLOGIST, 2003, 43 : 285 - 286
  • [12] Prescription Drug Coverage and Outcomes of Myeloma Therapy Among Medicare Beneficiaries
    Olszewski, Adam J.
    Dusetzina, Stacie B.
    Trivedi, Amal N.
    Davidoff, Amy J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (28) : 2879 - +
  • [13] The Effect of Supplemental Medical and Prescription Drug Coverage on Health Care Spending for Medicare Beneficiaries with Cancer
    Erten, Mujde Z.
    Davidoff, Amy J.
    Zuckerman, Ilene H.
    Shaffer, Thomas
    Dougherty, J. Samantha
    Ke, Xuehua
    Stuart, Bruce
    [J]. VALUE IN HEALTH, 2014, 17 (01) : 15 - 21
  • [14] Effect of Prescription Drug Coverage on the Elderly's Use of Prescription Drugs
    Khan, Nasreen
    Kaestner, Robert
    [J]. INQUIRY-THE JOURNAL OF HEALTH CARE ORGANIZATION PROVISION AND FINANCING, 2009, 46 (01) : 33 - 45
  • [15] Prescription drug coverage among elderly and disabled Americans: can Medicare—Part D reduce inequities in access?
    Panos Kanavos
    Marin Gemmill-Toyama
    [J]. International Journal of Health Care Finance and Economics, 2010, 10 : 203 - 218
  • [16] A political history of medicare and prescription drug coverage
    Oliver, TR
    Lee, PR
    Lipton, HL
    [J]. MILBANK QUARTERLY, 2004, 82 (02): : 283 - +
  • [17] Prescription-drug coverage for Medicare beneficiaries
    Iglehart, JK
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (10): : 923 - 925
  • [18] Prescription drug coverage satisfaction and medication nonadherence among Medicare beneficiaries with cancer
    Silverman, Ciara
    Ng, Boon Peng
    Baek, Chaewon
    Park, Chanhyun
    [J]. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2022, 22 (06) : 971 - 979
  • [19] Prescription drug coverage among elderly and disabled Americans: can Medicare-Part D reduce inequities in access?
    Kanavos, Panos
    Gemmill-Toyama, Marin
    [J]. INTERNATIONAL JOURNAL OF HEALTH CARE FINANCE & ECONOMICS, 2010, 10 (03): : 203 - 218
  • [20] PRESCRIPTION DRUG COVERAGE TYPE, OUT-OF-POCKET SPENDING, AND COST-RELATED NONADHERENCE AMONG MEDICARE BENEFICIARIES WITH RHEUMATOID ARTHRITIS
    Zheng, D.
    Thomas, J.
    [J]. VALUE IN HEALTH, 2020, 23 : S230 - S230